title: Alopecia associated with strontium ranelate use in a 62-year-old woman.
abstract: Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1 week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped because of the intractable headache. Nevertheless, the patient continued to lose hair for 6 weeks following treatment discontinuation. Histopathological analysis of scalp tissues revealed anagen effluvium. The patient's hair started regrowing slowly 2 months after treatment with strontium ranelate was discontinued.
authors.affiliation: Department of Dermatology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China.
authors.forename: Y-Y
authors.initials: YY
authors.lastname: Lee
authors.forename: C-H
authors.initials: CH
authors.lastname: Yang
authors.forename: C-H
authors.initials: CH
authors.lastname: Chen
authors.forename: J-S
authors.initials: JS
authors.lastname: Hwang
mesh_terms: D000505:Alopecia / Q000139:chemically induced* / Q000473:pathology; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009942:Organometallic Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate